Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronan Swords

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Current Hematologic Malignancy Reports|April 29, 2010
Second-generation tyrosine kinase inhibitors as therapy for chronic myeloid leukemiaRonan Swords, Yesid Alvarado, Jorge Cortes, et al.
Drugs|October 12, 2007
Treatment of acute lymphoblastic leukaemia : a new eraEffrosyni Apostolidou, Ronan Swords, Yesid Alvarado, et al.
Expert Review of Hematology|July 12, 2012
EPHA3 as a novel therapeutic target in the hematological malignanciesNiamh Keane, Ciara Freeman, Ronan Swords, et al.
Leukemia & Lymphoma|April 22, 2024
Evaluating targeted therapies in older patients with <i>TP53</i>-mutated AMLJean M G Sabile, Ronan Swords, Jeffrey W Tyner
Expert Review of Hematology|February 5, 2013
Elacytarabine: lipid vector technology under investigation in acute myeloid leukemiaNiamh Keane, Ciara Freeman, Ronan Swords, et al.
Drug Design, Development and Therapy|November 19, 2009
Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinibRonan Swords, Devalingam Mahalingam, Swaminathan Padmanabhan, et al.
Expert Review of Hematology|November 19, 2010
Clinical activity of laromustine (Onrigin™) in hematologic malignanciesYesid Alvarado, Ronan Swords, Kevin R Kelly, et al.
Targeted Oncology|April 22, 2009
Serosal inflammation (pleural and pericardial effusions) related to tyrosine kinase inhibitorsKevin Kelly, Ronan Swords, Devalingam Mahalingam, et al.
Future Oncology (London, England)|May 8, 2013
New prospects for drug development: the hedgehog pathway revealed. Focus on hematologic malignanciesAgustin Pimentel, Michel Velez, Luz J Barahona, et al.
Advances in Experimental Medicine and Biology|May 14, 2014
The role of inflammation in leukaemiaFrancis J Giles, Janusz Krawczyk, Michael O'Dwyer, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Current Hematologic Malignancy Reports|April 29, 2010
Second-generation tyrosine kinase inhibitors as therapy for chronic myeloid leukemiaRonan Swords, Yesid Alvarado, Jorge Cortes, et al.
Drugs|October 12, 2007
Treatment of acute lymphoblastic leukaemia : a new eraEffrosyni Apostolidou, Ronan Swords, Yesid Alvarado, et al.
Expert Review of Hematology|July 12, 2012
EPHA3 as a novel therapeutic target in the hematological malignanciesNiamh Keane, Ciara Freeman, Ronan Swords, et al.
Leukemia & Lymphoma|April 22, 2024
Evaluating targeted therapies in older patients with <i>TP53</i>-mutated AMLJean M G Sabile, Ronan Swords, Jeffrey W Tyner
Expert Review of Hematology|February 5, 2013
Elacytarabine: lipid vector technology under investigation in acute myeloid leukemiaNiamh Keane, Ciara Freeman, Ronan Swords, et al.
Drug Design, Development and Therapy|November 19, 2009
Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinibRonan Swords, Devalingam Mahalingam, Swaminathan Padmanabhan, et al.
Expert Review of Hematology|November 19, 2010
Clinical activity of laromustine (Onrigin™) in hematologic malignanciesYesid Alvarado, Ronan Swords, Kevin R Kelly, et al.
Targeted Oncology|April 22, 2009
Serosal inflammation (pleural and pericardial effusions) related to tyrosine kinase inhibitorsKevin Kelly, Ronan Swords, Devalingam Mahalingam, et al.
Future Oncology (London, England)|May 8, 2013
New prospects for drug development: the hedgehog pathway revealed. Focus on hematologic malignanciesAgustin Pimentel, Michel Velez, Luz J Barahona, et al.
Advances in Experimental Medicine and Biology|May 14, 2014
The role of inflammation in leukaemiaFrancis J Giles, Janusz Krawczyk, Michael O'Dwyer, et al.
Pageof 6